Drug intelligence / Profile preview

Fu-Zheng Qing-Fei empirical formula

Development stage: Unknown
Lead developer: Zhengzhou People's Hospital
Administration: Oral

Overview

Fu-Zheng Qing-Fei empirical formula is a traditional Chinese medicine (TCM) therapeutic regimen developed by Zhengzhou People's Hospital for the treatment of non-critical COVID-19 and viral pneumonia. The formula is based on the TCM therapeutic principles of Fu-Zheng (strengthening the body's vital energy and immune resistance) and Qing-Fei (clearing heat and toxins from the lungs to resolve inflammation). In the clinical trial ChiCTR2000030896, this empirical formula was administered as an adjunctive therapy alongside standard Western medicine to evaluate its effectiveness in improving clinical outcomes and safety in adult patients with novel coronavirus pneumonia.

Other names: Fu-Zheng Qing-Fei decoctionFu-Zheng Qing-Fei formulaFu-Zheng Qing-Fei concept

Beyond the preview

Go deeper on Fu-Zheng Qing-Fei empirical formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fu-Zheng Qing-Fei empirical formula.

Explore the full profile